ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Discover which index funds are top rated for retirement in 2024 and why they matter for your portfolio. Learn about performance, fees, and diversification.
25,383 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
American Express is scrapping its long-standing unit-by-unit bonus race. The company now ties executive pay to overal...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
As Nasdaq volatility surges amid broader market jitters, one sub-$20 tech stock with a near-monopoly in a niche data ...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...
A viral incident can change how people see you—and how money moves. This article uses the moment around shia labeouf ...
Facing rising interest rates and tighter lending, many investors reassess their rental portfolios. Here’s a practical...
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
Apple stock has turned heads for years with strong profitability and a steady drip of shareholder rewards. This artic...
Analysts issued fresh price targets on nine stocks, signaling divergent views as U.S. markets contend with rate uncer...
AI disruption is rattling markets, but Bitcoin still has unique safeguards. This guide explains why bitcoin safe from...